NEW YORK, April 13 – For months, market watchers have been predicting that the structural proteomics market would undergo a period of consolidation. With too many small companies specializing in narrowly focused technologies, they said, it was only a matter of time before they joined together to provide big pharma with a more complete package. Perhaps that time has come.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.